Delivery Order SPE2DB22D3004-SPE2DB25FPH18

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX8EF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $45,082.30, is a Firm Fixed Price Delivery Order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB24FF8FL, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with a ceiling value of $6,768.45 and a period of performance through May 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA2D7, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $1,510.60, is a delivery order for the pharmaceutical product HUMIRA PEN 40 MG/0.8 MLS. It is a firm-fixed-price contract with a completion date of January 24, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award SPE2DB20D3103|SPE2DB25FL3Q5, valued at $6,545.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of October 16, 2024. The contract does not have a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $3,583.36, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a firm fixed-price arrangement and...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office division a $45,349.28 firm-fixed-price delivery order contract for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs...
The federal contract award, with ID SPE2DB22D1017|SPE2DB24FG2WF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,694.32 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. This contract is not set aside for any specific business type. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen, through its Corporate Office division, has been...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $28,097.94, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a period of performance ending on August 27, 2024. This is a Firm Fixed Price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, with ID SPE2DB22D3009|SPE2DB24FAP15, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $43,454.42 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, and has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
The federal contract award, valued at $2,559.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Humira(CF) Pen 40 mg/0.4 mls pharmaceutical products. This is a firm fixed-price delivery order contract, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPH18
    Delivery Order

The federal contract award, with ID SPE2DB22D3004|SPE2DB25FPH18, was granted by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $2,265.90, is for the delivery of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This is a firm fixed-price delivery order contract with a completion date of January 30, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, which serve as primary vehicles for providing a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs.

Generated 4/30/25, 10:11 AM